| B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres D Nehama, N Di Ianni, S Musio, H Du, M Patané, B Pollo, G Finocchiaro, ... EBioMedicine 47, 33-43, 2019 | 126 | 2019 |
| Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ... Science translational medicine 10 (430), eaao2731, 2018 | 120 | 2018 |
| Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells AR Farina, L Cappabianca, G DeSantis, N Di Ianni, P Ruggeri, M Ragone, ... FEBS letters 585 (20), 3328-3336, 2011 | 63 | 2011 |
| The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma S Pessina, G Cantini, D Kapetis, E Cazzato, N Di Ianni, G Finocchiaro, ... Oncoimmunology 5 (5), e1108513, 2016 | 34 | 2016 |
| High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient E Anghileri, N Di Ianni, R Paterra, T Langella, J Zhao, M Eoli, M Patanè, ... Cancer Immunology, Immunotherapy 70, 831-842, 2021 | 27 | 2021 |
| Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma C Corbetta, N Di Ianni, MG Bruzzone, M Patanè, B Pollo, G Cantini, ... International journal of cancer 144 (10), 2539-2554, 2019 | 27 | 2019 |
| The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria … P Ruggeri, AR Farina, N Di Ianni, L Cappabianca, M Ragone, G Ianni, ... PLoS One 9 (4), e94568, 2014 | 27 | 2014 |
| Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin AR Farina, L Cappabianca, P Ruggeri, N Di Ianni, M Ragone, S Merolle, ... FEBS letters 586 (20), 3681-3691, 2012 | 27 | 2012 |
| Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy M Eoli, C Corbetta, E Anghileri, N Di Ianni, M Milani, V Cuccarini, S Musio, ... Neuro-oncology advances 1 (1), vdz022, 2019 | 24 | 2019 |
| ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell … S Pellegatta, N Di Ianni, S Pessina, R Paterra, E Anghileri, M Eoli, ... International Journal of Molecular Sciences 20 (23), 5886, 2019 | 20 | 2019 |
| Altered metabolism in glioblastoma: Myeloid-derived suppressor cell (MDSC) fitness and tumor-infiltrating lymphocyte (TIL) dysfunction N Di Ianni, S Musio, S Pellegatta International journal of molecular sciences 22 (9), 4460, 2021 | 16 | 2021 |
| TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH‐SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype AR Farina, N Di Ianni, L Cappabianca, P Ruggeri, M Ragone, G Ianni, ... BioMed Research International 2013 (1), 740187, 2013 | 16 | 2013 |
| Revisiting the immunological aspects of temozolomide considering the genetic landscape and the immune microenvironment composition of glioblastoma N Di Ianni, M Maffezzini, M Eoli, S Pellegatta Frontiers in Oncology 11, 747690, 2021 | 13 | 2021 |
| Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain AR Farina, L Cappabianca, N Di Ianni, P Ruggeri, M Ragone, S Merolle, ... FEBS letters 586 (16), 2366-2374, 2012 | 13 | 2012 |
| Neurotrophin and neurotrophin receptor involvement in human neuroblastoma P Ruggeri, AR Farina, L Cappabianca, N Di Ianni, M Ragone, S Merolle, ... Neuroblastoma, 2013 | 11 | 2013 |
| Deciphering the labyrinthine system of the immune microenvironment in recurrent glioblastoma: recent original advances and lessons from clinical immunotherapeutic approaches E Anghileri, M Patanè, N Di Ianni, I Sambruni, M Maffezzini, M Milani, ... Cancers 13 (24), 6156, 2021 | 9 | 2021 |
| TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the … L Gneo, P Ruggeri, L Cappabianca, AR Farina, N Di Ianni, AR Mackay Oncotarget 7 (49), 80820, 2016 | 9 | 2016 |
| Alternative TrkA splicing and neuroblastoma AR Farina, L Cappabianca, P Ruggeri, N Di Ianni, M Ragone, S Merolle, ... Neuroblastoma-Present and Future, 2012 | 7 | 2012 |
| Constitutive and TNF-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ... Sci. Transl. Med 10, 2018 | 4 | 2018 |
| PO-1827 M1 microglia polarization induced by radiotherapy and dendritic cell immunotherapy combination. V Pinzi, N Di Ianni, ML Fumagalli, M Maffezzini, L Fariselli, S Pellegatta Radiotherapy and Oncology 170, S1624, 2022 | | 2022 |
